March 28th 2023
Durvalumab plus tremelimumab and hypofractionated radiotherapy yields observable clinical benefits in patients with gynecologic cancers, according to an expert from The University of Texas MD Anderson Cancer Center.
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
The 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
Community Practice Connections®: How Are We Personalizing Integration of ICIs and Targeted Therapies to Optimize Outcomes in Endometrial Cancer?
Medical Crossfire®: How Are We Personalizing Integration of ICIs and Targeted Therapies to Optimize Outcomes in Endometrial Cancer?
Medical Crossfire®: How Are We Integrating Immune Checkpoint Inhibitors and Targeted Therapies to Personalize Therapy in Endometrial Cancer?
Addressing Racial and Ethnic Disparities in Breast Cancer Care: Improving Outcomes Across the Spectrum of Diagnosis, Trial Access, and Patient Care
Burst CME™: What You Need to Know About the Evolving Role of TIL Therapy in Cancer Treatment
Carboplatin/Paclitaxel Induction in Ovarian Cancer: The Finer PointsAugust 15th 2018
The regimen consisting of carboplatin and paclitaxel represents the backbone of ovarian cancer treatment. Here, we reflect on our experience administering the carboplatin/paclitaxel regimen to scores of ovarian cancer patients over the past decade and a half.
MGH Program Supports Sexual Health of Women Receiving Pelvic RT for Gastrointestinal and Gynecologic MalignanciesJuly 18th 2018
In an interview with Cancer Network, Lorraine Drapek describes a multidisciplinary program at MGH to support vaginal and sexual health post RT for GI and gynecologic malignancies.
HIPEC Increases Survival in Advanced Ovarian Cancer Over Surgery AloneJanuary 17th 2018
Treatment with hyperthermic intraperitoneal chemotherapy along with cytoreductive surgery resulted in better survival outcomes than surgery alone in patients with stage III epithelial ovarian cancer, according to a new study.